Real-world data show bariatric surgery helps patients lose about 24% of body weight in three years, vastly outperforming GLP‑1 drugs like semaglutide or tirzepatide (5–7% loss). This puts surgery ahead for sustained weight reduction, though combining treatments may further boost outcomes. Concurrently, new tools include a blood test to detect liver transplant damage via DNA fragments and muscle ultrasound techniques that flag early insulin resistance—potential screens for metabolic issues before type 2 diabetes onset.
Source: Reuters Health reuters.com